Skip to content

Contact +44 (0) 20 7060 7474 email us

Clinical Trials

Opthalmoscope Clinical Trial Analysis

 

Publication Date July 2009
Publisher Global Markets Direct
Product Type
Pages 22
ISBN Number not applicable
Product Code GMD02922

Price

£660.00
approximately: $999 | €737

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Global Markets Direct's "Opthalmoscope Clinical Trials Analysis" is an essential source of data and information pertaining to product clinical trials being carried out by Opthalmoscope manufacturers, globally. The report provides exhaustive information on each clinical investigation study with coverage detailed coverage on the pipeline products these trials are being carried out for.

Scope

  • The report provides analysis and review of the key clinical trials being carried out globally and across key Opthalmoscope market categories - Opthalmoscope
  • The report covers information on each product being clinically tested with detailed coverage on the pipeline product profile, the indication it's being investigated for etc.
  • The report provides an in-depth analysis of the clinical trials with information on trial phase, trial 0status, trial acronym, purpose, inclusion and exclusion criteria, description, design, intervention, investigator information, primary and secondary end-points and trial results
  • The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct's team of industry experts.

Reasons to Buy

  • Effectively plan your Mergers and Acquisitions and partnership strategies by identifying companies with the most promising pipeline.
  • Stay ahead of the information curve in the fast changing Opthalmoscope market.
  • Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Proactively plan and execute your competitive strategies by identifying clinical trials status of the leading competitive products in pipeline.
  • Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

Contents

  • 1 List of Tables
  • 1.2 List of Figures
  • 2 Opthalmoscope Clinical Trials
    • 2.1 Opthalmoscope Clinical Trial By Equipment Type
    • 2.2 Opthalmoscope Clinical Trials By Trial Phase and Trial Status
    • 2.3 Opthalmoscope Pipeline Products By Development Stage
    • 2.4 Opthalmoscope Pipeline Products By Therapy Area
    • 2.5 Opthalmoscope Pipeline Products By News Summary
    • 2.6 Opthalmoscope Implantable Miniature Telescope
      • 2.6.1 A Prospective Multicenter Clinical Study of the Implantable Miniature Telescope in Patients With Central Vision Impairment Associated With AMD: IMT-UK Protocol (IMT by Dr. Isaac Lipshitz)
      • 2.6.2 Phase I U.S. IMT-001 trial
      • 2.6.3 IMT002 trial
    • 2.7 Opthalmoscope MicroEYE ophthalmic imaging system
      • 2.7.1 microEYE Clinical Evaluation
  • 3 Recent Developments
    • 3.1 Product News
      • 3.1.1 Jun 23, 2009: Canon Unveils The CR-1 Mark II Digital Non-Mydriatic Retinal Camera For Eyecare Professionals
      • 3.1.2 Jun 10, 2009: FDA Grants 510(k) Approval To EyeIC's MatchedFlicker Retinal Aid Detection Technology
      • 3.1.3 Mar 30, 2009: FDA Advisory Panel Recommends Approval Of VisionCare's Implantable Telescope For End-Stage Macular Degeneration
      • 3.1.4 Jul 31, 2008: Paradigm Medical Sells Early Detection Instrument For Glaucoma
      • 3.1.5 Jul 14, 2008: Paradigm Medical Industries Records Initial Sales Of Early Glaucoma Detection Device
      • 3.1.6 Nov 01, 2006: Results Of Implantable Telescope Trial Report On Vision And Quality Of Life In Patients With End-Stage Age-Related Macular Degeneration
      • 3.1.7 Oct 11, 2005: VisionCare Announces Presentations On Pivotal Trial Results At The American Academy Of Ophthalmology Annual Meeting
    • 3.2 Product Approvals
      • 3.2.1 Jun 10, 2009: FDA Grants 510(k) Approval To EyeIC's MatchedFlicker Retinal Aid Detection Technology
  • 4 Appendix
    • 4.1 Methodology
      • 4.1.1 Coverage
      • 4.1.2 Secondary Research
      • 4.1.3 Primary Research
      • 4.1.4 Expert Panel Validation
    • 4.2 Contact Us
    • 4.3 About Global Markets Direct
    • 4.4 Disclaimer
  • 1 List of Tables
    • Table 1: Opthalmoscope Clinical Trial By Equipment Type
    • Table 2: Opthalmoscope Clinical Trials By Trial Phase and Trial Status
    • Table 3: Opthalmoscope Pipeline Products By Development Stage
    • Table 4: Opthalmoscope Pipeline Products By Therapy Area
    • Table 5: Opthalmoscope Pipeline Products By News Summary
    • Table 6: Implantable Miniature Telescope - A Prospective Multicenter Clinical Study of the Implantable Miniature Telescope in Patients With Central Vision Impairment Associated With AMD: IMT-UK Protocol (IMT by Dr. Isaac Lipshitz)
    • Table 7: Implantable Miniature Telescope - Phase I U.S. IMT-001 trial
    • Table 8: Implantable Miniature Telescope - IMT002 trial
    • Table 9: MicroEYE ophthalmic imaging system - microEYE Clinical Evaluation
  • 1.2 List of Figures
    • Figure 1: Global Markets Direct Methodology